Abstract
Crohn’s disease (CD), a chronic inflammatory bowel condition, although rare in Malaysia, can present with atypical systemic features, including reproductive dysfUnction. We report the case of a 31-year-old woman referred for secondary amenorrhoea and presumed endometriosis, later diagnosed with CD following worsening gastrointestinal symptoms and significant weight loss. Hormonal evaluation revealed hypothalamic-pituitary axis suppression secondary to malnutrition and systemic inflammation. Treatment with corticosteroids and nutritional rehabilitation led to weight gain and resumption of menses within 3 months. This case highlights the importance of recognising functional hypothalamic amenorrhoea as a reversible consequence of chronic illness and nutritional deficiency. It also underscores how systemic diseases such as CD may mimic gynaecological conditions, potentially delaying accurate diagnosis. Early multidisciplinary collaboration is essential in evaluating menstrual disturbances with overlapping gastrointestinal symptoms, especially in regions where inflammatory bowel disease remains uncommon.
Keywords: Crohn's disease, Amenorrhoea, Functional hypothalamic amenorrhoea, Malnutrition, Inflammatory bowel disease
Introduction
Inflammatory bowel disease (IBD), namely ulcerative colitis (UC) and Crohn’s disease (CD), is relatively rare in Malaysia, with a mean incidence of 0.69 per 100,000 population. The rate is higher among Indians, at 1.91 per 100,000, and is followed by that among the Chinese and Malays, at 0.63 and 0.35, respectively.1 After 25 years of age, women have a 16%–47% higher risk of CD than men, according to an age-stratified meta-analysis.2
Patients with CD typically present with abdominal pain, chronic diarrhoea, weight loss and fatigue.3 In women, pain caused by CD might be mistaken as dysmenorrhoea, for which treatment may worsen the course of CD.4,5 CD can disrupt the hypothalamic-pituitary–ovarian axis through chronic inflammation, malnutrition and psychological stress, thus causing menstrual irregularities and amenorrhoea in 30% of cases,6 reduced fertility and adverse pregnancy outcomes.7
Due to the rarity of the disease in Asia, the abovementioned reproductive concerns are often under-recognised, especially when gastrointestinal symptoms are pronounced. This case report details the case of a young woman with newly diagnosed CD who was referred for evaluation of secondary amenorrhoea. Although she was initially suspected to have endometriosis, further workup revealed functional hypothalamic suppression, likely driven by chronic inflammation and significant weight loss due to CD. This case highlights the complex interplay between gastrointestinal and reproductive health in chronic disease. It also underscores the need for early recognition and intervention in evaluating menstrual disturbances, mainly when they occur in the setting of systemic symptoms.
Case presentation
A 31-year-old Malay woman, para 1, whose last childbirth was 2 years ago, was referred to the gynaecology team for further investigation and management of secondary amenorrhoea. Her last menses occurred 6 months ago. She had attained her menarche at the age of 14 years with irregular cycles, once in 3 to 4 months, each lasting for 5 days. She experienced dysmenorrhoea, requiring occasional paracetamol or mefenamic acid ever since. She also reported passing out loose stools prior to or during menses.
About a year after her marriage, the patient conceived her child spontaneously. The pregnancy was uneventful. She delivered her child via spontaneous vaginal delivery at term. Her baby was alive and well.
The dysmenorrhoea worsened over the last year, causing her to have multiple hospital admissions. The pain improved with parenteral analgesia each time. Approximately 6 months prior to this presentation, during one of her admissions for dysmenorrhoea, a presumptive diagnosis of endometriosis was made based on her symptoms and clinical assessment. She was started on combined oral contraceptive pills (COCPs), which failed to improve her condition. Therefore, she did not return for any follow-up until her current admission.
Since the last 6 months, she reported persistent vomiting and diarrhoea, causing her to have poor oral intake and lethargy. She lost 20 kg over the same period. She stopped having menses since then. There was no history of tenesmus, dyschezia or haematochezia. Her family history was unremarkable.
Upon assessment, she looked cachexic, with fat and muscle mass loss in the temporal region and upper and lower limbs (Figures 1 and 2). Her height was 162 cm, and her weight was 35 kg, yielding a BMI of 13.3 kg/m2. She was pale and dehydrated. Her vital signs were otherwise normal. Apart from having a scaphoid abdomen, the patient showed no other abnormality.
Figure 1. Temporal wasting indicating significant malnutrition.

Figure 2. Severe muscle and fat wasting over the upper and lowerlimbs.

Pelvic ultrasound revealed a normal-sized uterus with bilaterally normal ovaries. Colonoscopy demonstrated features of CD (Figure 3), which was confirmed by tissue histology. She showed markedly reduced follicle-stimulating hormone (0.43 IU/L), luteinising hormone (<0.3 IU/L) and oestradiol levels (<18.4 pmol/L), indicating hypothalamic-pituitary suppression.
Figure 3. Colonoscopic image showing characteristic cobblestone appearance and ulcerationtypical ofCrohn’s disease.

The patient was treated with a course of corticosteroids, for which she gained1.5 kgafter only 2 days oftreatment. Shehad gained a total of 10 kg after 3 months of treatment and had spontaneouslyresumedhermenses.
Discussion
This case illustrates the under-recognised reproductive consequences of CD in women of reproductive age, particularly in populations where CD remains uncommon. The patient presented with classic gastrointestinal symptoms of CD, yet her referral to the gynaecology team for secondary amenorrhoea prompted a broader multidisciplinary evaluation, leading to accurate diagnosis and appropriate management.
Menstrual dysfunction, including amenorrhoea, has been reported in up to 30% of women with IBD, particularly during active disease phases.8,9 In this patient, the profound weight loss, malnutrition and systemic inflammation were consistent with functional hypothalamic amenorrhoea. This condition arises from suppression of the hypothalamic-pituitary-gonadal axis due to inadequate energy availability, psychological stress and inflammatory cytokines.9,10
Malnutrition, especially a low BMI (<18.5 kg/m2), is a well-documented trigger for hypothalamic suppression, with leptin levels playing a central role. Leptin, secreted by adipose tissue, is necessary for GnRH pulsatility; low levels disrupt gonadotropin release, causing anovulation and amenorrhoea. This patient’s BMI of 13.3 kg/m2 strongly supports this mechanism. Chronic inflammation in CD can also impair gonadotropin secretion through elevated levels of cytokines such as IL-1, IL-6 and TNF-α.11
The initial misdiagnosis of endometriosis is common, given that abdominal pain and dysmenorrhoea can overlap with gastrointestinal symptoms. Studies have shown that women with CD frequently report dysmenorrhoea-like symptoms, which may be exacerbated during menstruation.11 However, treating such patients with hormonal therapies, COCPs in this patient, without addressing the underlying systemic illness, may mask key features and delay appropriate care. COCPs are believed to exacerbate the development and relapse of CD and UC.12,13 COCP users have a 46% higher risk of having CD or CD relapse (RR=1.46, 95% CI= 1.26-1.70).14 The exact mechanisms through which COCPs exacerbate CD are not known. However, oestrogen is linked to the inhibition of TH1-mediated cytokines and stimulation of TH2-mediated cytokines, which induce inflammatory conditions, finally leading to intestinal microvasculature thrombosis,15-17 believed to be the pathogenesis of IBD.18,19 Although patients with IBD generally maintain fertility during disease remission, active disease can impair fertility indirectly through complications such as malnutrition, pelvic inflammation and altered sexual behaviour due to pain or fatigue.20
Importantly, this case demonstrates that hypothalamic amenorrhoea is reversible with appropriate nutritional rehabilitation and control of the underlying disease. The patient’s rapid weight gain following corticosteroid therapy and the resumption of spontaneous menses support this outcome. This reinforces the need for early identification and multidisciplinary management involving gastroenterologists, gynaecologists and dietitians to optimise outcomes in similar cases.
In the Malaysian context, where CD remains rare and underdiagnosed, awareness of its systemic manifestations, including menstrual disturbances, is critical for timely diagnosis and holistic care. As the incidence of IBD increases in Asia, primary care physicians and specialists alike must maintain a high index of suspicion when evaluating women presenting with overlapping gastrointestinal and reproductive symptoms.
Conclusion
CD can present with reproductive symptoms such as secondary amenorrhoea, especially when complicated by malnutrition and systemic inflammation.
Functional hypothalamic amenorrhoea should be considered in women with low BMI and menstrual irregularities.
Multidisciplinary evaluation is key to avoiding misdiagnosis and guiding appropriate treatment.
Early identification and treatment of underlying disease can reverse hypothalamic suppression and restore normal menstrual cycles.
Greater awareness of the extraintestinal manifestations of CD, especially in regions with rising incidence, is crucial for holistic patient care.
Acknowledgements
We would like to thank the patient for agreeing to publish her case and Hospital Pakar Universiti Sains Malaysia for giving us permission to publish this case.
Conflicts of interest
All authors do not have any conflicts of interest to declare.
Author contributions
Nageshar A and Vikiraman T co-managed and reviewed the case and provided details. Ibrahim A drafted, revised and finalised the manuscript. Omar AA reviewed the manuscript and provided suggestions. All authors agreed with the results and conclusion.
Patient’s consent for the use of images and content for publication
Verbal consent was obtained from the patient prior to image collection. The images were shown to the patient. Subsequently, she was discharged.
Consent to use the images and content for publication in the Malaysian Family Physician was also obtained from the patient via telephone conversation. The patient agreed to let one of the authors sign on her behalf under the ‘Consent by Author’ section.
What is new in this case report compared to the previous literature?
Hypothalamic amenorrhoea as a presenting feature of Crohn’s disease (CD) has been seldom described, especially among Southeast Asians.
This patient was initially misdiagnosed with endometriosis and treated with combined oral contraceptive pills, which may contribute to inflammatory bowel disease development.
The link between severe malnutrition, hormonal suppression and menstrual disturbance highlights the reversible nature of hypothalamic amenorrhoea in CD.
The case underscores the importance of a multidisciplinary approach involving gastroenterology, gynaecology and nutrition for timely diagnosis and effective treatment.
It contributes to limited data on CD in Malaysian women and highlights the disease’s systemic implications beyond the gastrointestinal tract.
What is the implication to patients?
This case highlights the importance of recognising systemic illness, such as CD, as a potential underlying cause of menstrual dysfunction. It underscores the need for a multidisciplinary approach to avoid misdiagnosis and to prevent unnecessary gynaecological interventions, such as starting combined oral contraceptive pills, which could worsen CD. Hypothalamic amenorrhoea carries a good prognosis. It is reversible with appropriate medical and nutritional management, reassuring patients, and improves their reproductive health outcomes. Early diagnosis and comprehensive care can significantly enhance patients’ quality of life by restoring normal menstrual function and addressing the root cause of their symptoms.
References
- 1.Hilmi I, Jaya F, Chua A, Heng WC, Singh H, Goh KL. A first study on the incidence and prevalence of IBD in Malaysia--results from the Kinta Valley IBD Epidemiology Study. J Crohns Colitis. 2015 May;9(5):404–409. doi: 10.1093/ecco-jcc/jjv039. [DOI] [PubMed] [Google Scholar]
- 2.Shah SC, Khalili H, Gower-Rousseau C, et al. Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from Western countries. Gastroenterology. 2018;155:1079–1089. doi: 10.1053/j.gastro.2018.09.014. [DOI] [PubMed] [Google Scholar]
- 3.Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389(10080):1741–1755. doi: 10.1016/S0140-6736(16)31711-1. [DOI] [PubMed] [Google Scholar]
- 4.Saha S, Midtling E, Roberson E, Nair VA, Wald A, Reichelderfer M. Dysmenorrhea in women with Crohn’s disease: a case-control study. Inflamm Bowel Dis. 2013;19:1463–1469. doi: 10.1097/MIB.0b013e318281f3a9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lahat A, Falach-Malik A, Haj O, Shatz Z, Ben-Horin S. Change in bowel habits during menstruation: are IBD patients different? Therap Adv Gastroenterol. 2020 Jun;13:1756284820929806. doi: 10.1177/1756284820929806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Weber AM, Ziegler C, Belinson JL, Mitchinson AR, Widrich T, Fazio V. Gynecologic history of women with inflammatory bowel disease. Obstet Gynecol. 1995;86:843–847. doi: 10.1016/0029-7844(95)00286-Z. [DOI] [PubMed] [Google Scholar]
- 7.Armuzzi A, Bortoli A, Castiglione F, et al. Female reproductive health and inflammatory bowel disease: a practice-based review. Dig LiverDis. 2022;54(1):19–29. doi: 10.1016/j.dld.2021.05.020. [DOI] [PubMed] [Google Scholar]
- 8.Kalantaridou SN, Makrigiannakis A, Zoumakis E, Chrousos GP. Stress and the female reproductive system. J Reprod Immunol. 2004;62(1-2):6l–68. doi: 10.1016/j.jri.2003.09.004. [DOI] [PubMed] [Google Scholar]
- 9.Gordon CM, Ackerman KE, Berga SL, et al. Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(5):1413–1439. doi: 10.1210/jc.2017-00131. [DOI] [PubMed] [Google Scholar]
- 10.Malinauskiene V, Zuzo A, Liakina V, Kazenaite E, Stundiene I. Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology. World J Clin Cases. 2023 Jul;11(21):4989–4995. doi: 10.12998/wjcc.v11.i21.4989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Orlanski Meyer E, Buchuk R, Ben Tov A, et al. P1116 Risk of fractures in children and adults with inflammatory bowel disease: a report from the Epi-IIRN. J Crohns Colitis. 2024;18:i2002–i2003. doi: 10.1093/ecco-jcc/jjad212.1246. [DOI] [Google Scholar]
- 12.Firman N, Palmer MJ, Timaeus IM, Wellings K. Contraceptive method use among women and its association with age, relationship status and duration: findings from the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3). BMJ Sex Reprod Heath. 2018;44:165–174. doi: 10.1136/bmjsrh-2017-200037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Pasvol TJ, Bloom S, Segal AW, Rait G, Horsfall L. Use of contraceptives and risk of inflammatory bowel disease: a nested case-control study. Aliment Pharmacol Ther. 2022 Feb;55(3):318–326. doi: 10.1111/apt.16647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103:2394–2400. doi: 10.1111/j.1572-0241.2008.02064.x. [DOI] [PubMed] [Google Scholar]
- 15.Salem ML. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy. 2004;3:97–104. doi: 10.2174/1568010043483944. [DOI] [PubMed] [Google Scholar]
- 16.Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007;102:174–186. doi: 10.1111/j.1572-0241.2006.00943.x. [DOI] [PubMed] [Google Scholar]
- 17.Wakefield A, Sawyerr A, Hudson M, Dhillon A, Pounder R. Smoking, the oral contraceptive pill, and Crohn’s disease. DigDis Sci. 1991;36:1147–1150. doi: 10.1007/BF01297463. [DOI] [PubMed] [Google Scholar]
- 18.Cutolo M, Capellino S, Straub RH. Oestrogens in rheumatic diseases: friend or foe? Rheumatology. 2008;47(Suppl 3):iii2–iii5. doi: 10.1093/rheumatology/ken150. [DOI] [PubMed] [Google Scholar]
- 19.González DA, Díaz BB, Rodríguez Pérez MDC, Hernández AG, Chico BND, de León AC. Sex hormones and autoimmunity. Immunol Lett. 2010;133:6–13. doi: 10.1016/j.imlet.2010.07.001. [DOI] [PubMed] [Google Scholar]
- 20.West LB, Gilkey RM, Turner AL. Fertility and reproductive health in women with inflammatory bowel disease: an overview of current findings. J Gastroenterol. 2020;53(4):295–305. [Google Scholar]
